{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:01:55Z","timestamp":1787029315115,"version":"build-2736575974"},"reference-count":23,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Cancer Society New Zealand","award":["Project Grant 2020"],"award-info":[{"award-number":["Project Grant 2020"]}]},{"DOI":"10.13039\/501100001537","name":"University of Auckland","doi-asserted-by":"publisher","award":["PhD Scholarship"],"award-info":[{"award-number":["PhD Scholarship"]}],"id":[{"id":"10.13039\/501100001537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>The compounds 2-amino-3-carboxamido-thieno[2,3-b]pyridines have demonstrated excellent anti-proliferative activity against human cancer cell lines, including the triple-negative breast cancer cell line MDA-MB-231. In this study, 81 novel thieno[2,3-b]pyridines were synthesised in four series to further improve their anti-proliferative activity, in particular by targeting an adjacent lipophilic pocket in the putative target enzyme phosphoinositide phospholipase C (PI-PLC). Overall, it was found that appending a propyl-aryl group at C-5 on 2-amino-3-carboxamido-thieno[2,3-b]pyridine resulted in compounds with potent biological activity, exhibiting IC50 values in the nanomolar range. The propyl linker could be an \u03b1,\u03b2-unsaturated ketone or a saturated propyl ketone, but the highest activity was obtained when allylic alcohols were the tether between thieno[2,3-b]pyridine and the appended aryl group, with compound 21r having IC50 values lower than 50 nM. Compounds with one extra carbon in the tether (i.e., a four-atom chain) were found to be considerably less active. Molecular modelling revealed this propyl tether places the newly introduced aryl ring in an untargeted lipophilic pocket within the active site of the phosphoinositide phospholipase C (PI-PLC) enzyme.<\/jats:p>","DOI":"10.3390\/pharmaceutics13122020","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T02:34:05Z","timestamp":1638326045000},"page":"2020","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Tethered Aryl Groups Increase the Activity of Anti-Proliferative Thieno[2,3-b]Pyridines by Targeting a Lipophilic Region in the Active Site of PI-PLC"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2537-1882","authenticated-orcid":false,"given":"Natalie A.","family":"Haverkate","sequence":"first","affiliation":[{"name":"School of Chemical Sciences, University of Auckland, Auckland 1010, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6932-3188","authenticated-orcid":false,"given":"Euphemia","family":"Leung","sequence":"additional","affiliation":[{"name":"Auckland Cancer Society Research Centre, University of Auckland, Auckland 1023, New Zealand"},{"name":"Department of Molecular Medicine and Pathology, University of Auckland, Auckland 1023, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9292-3261","authenticated-orcid":false,"given":"Lisa I.","family":"Pilkington","sequence":"additional","affiliation":[{"name":"School of Chemical Sciences, University of Auckland, Auckland 1010, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3425-6552","authenticated-orcid":false,"given":"David","family":"Barker","sequence":"additional","affiliation":[{"name":"School of Chemical Sciences, University of Auckland, Auckland 1010, New Zealand"},{"name":"The MacDiarmid Institute for Advanced Materials and Nanotechnology, Victoria University of Wellington, Wellington 6012, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.bmc.2009.02.049","article-title":"The identi-fication of novel PLC-\u03b3 inhibitors using virtual high throughput screening","volume":"17","author":"Reynisson","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1039\/C5MD00245A","article-title":"A synthesis, in silico, in vitro and in vivo study of thieno[2,3-b]pyridine anticancer analogues","volume":"6","author":"Arabshahi","year":"2015","journal-title":"MedChemComm"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1039\/C3MD00290J","article-title":"The effect of a thieno[2,3-b]pyridine PLC-\u03b3 inhibitor on the proliferation, morphology, migration and cell cycle of breast cancer cells","volume":"5","author":"Leung","year":"2014","journal-title":"MedChemComm"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.bmc.2016.01.047","article-title":"Synthesis and cytotoxicity of thieno[2,3-b]quinoline-2-carboxamide and cycloal-kyl[b]thieno[3,2-e]pyridine-2-carboxamide derivatives","volume":"24","author":"Leung","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"10187","DOI":"10.1158\/0008-5472.CAN-08-1181","article-title":"Phospholipase C\u03b31 Is Required for Metastasis Development and Progression","volume":"68","author":"Sala","year":"2008","journal-title":"Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12935-016-0293-6","article-title":"Evidence that phos-pholipase C is involved in the antitumour action of NSC768313, a new thieno[2,3-b]pyridine derivative","volume":"16","author":"Reynisson","year":"2016","journal-title":"Cancer Cell Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s40487-021-00158-0","article-title":"Validating TDP1 as an Inhibition Target for the Development of Chemosensitizers for Camptothecin-Based Chemotherapy Drugs","volume":"9","author":"Leung","year":"2021","journal-title":"Oncol. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1039\/c3md00320e","article-title":"The development of thieno[2,3-b]pyridine analogues as anticancer agents applying in silico methods","volume":"5","author":"Arabshahi","year":"2014","journal-title":"MedChemComm"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zafar, A., Sari, S., Leung, E., Pilkington, L.I., Van Rensburg, M., Barker, D., and Reynisson, J. (2017). GPCR Modulation of Thieno[2,3-b]pyridine Anti-Proliferative Agents. Molecules, 22.","DOI":"10.3390\/molecules22122254"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.bmc.2016.11.041","article-title":"3-Amino-thieno[2,3-b]pyridines as microtubule-destabilising agents: Molecular modelling and biological evaluation in the sea urchin embryo and human cancer cells","volume":"25","author":"Eurtivong","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1021\/jm400043d","article-title":"Synthesis and Biological Evaluation of 2-(Alkoxycarbonyl)-3-Anilinobenzo[b]thiophenes and Thieno[2,3-b]pyridines as New Potent Anticancer Agents","volume":"56","author":"Romagnoli","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1021\/jm901647p","article-title":"Structure-Based Discovery of Novel Chemotypes for Adenosine A2A Receptor Antagonists","volume":"53","author":"Katritch","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.ejmech.2017.11.014","article-title":"Thieno[2,3-b]pyridine derivatives are potent anti-platelet drugs, inhibiting platelet activation, aggregation and showing synergy with aspirin","volume":"143","author":"Binsaleh","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_14","first-page":"118","article-title":"Antibacterial evaluation and molecular properties of pyrazolo[3,4-b] pyridines and thieno[2,3-b]pyridines","volume":"11","author":"Elsherif","year":"2021","journal-title":"J. Appl. Pharm. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1134\/S1068162021040117","article-title":"Synthesis, Characterization, and Antifungal Activity of Some New Thieno[2,3-b]pyridines Incorporating Quinazoline or Ben-zimidazole Moiety","volume":"47","author":"Ibrahim","year":"2021","journal-title":"Russ. J. Bioorg. Chem."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"458","DOI":"10.17344\/acsi.2020.6609","article-title":"Synthesis and Cytotoxicity of Thieno[2,3-b]Pyridine Derivatives Toward Sensitive and Multidrug-Resistant Leukemia Cells","volume":"68","author":"Tarawneh","year":"2021","journal-title":"Acta Chim. Slov."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"116092","DOI":"10.1016\/j.bmc.2021.116092","article-title":"Improving the solubility of anti-proliferative thieno[2,3-b]quinoline-2-carboxamides","volume":"37","author":"Haverkate","year":"2021","journal-title":"Bioorganic Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bmcl.2016.12.009","article-title":"Synthesis and antiproliferative activity of 2-chlorophenyl carboxamide thienopyridines","volume":"27","author":"Leung","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Zafar, A., Pilkington, L.I., Haverkate, N.A., Van Rensburg, M., Leung, E., Kumara, S., Denny, W.A., Barker, D., Alsuraifi, A., and Hoskins, C. (2018). Investigation into Improving the Aqueous Solubility of the Thieno[2,3-b]pyridine Anti-Proliferative Agents. Molecules, 23.","DOI":"10.3390\/molecules23010145"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1055\/s-0036-1588619","article-title":"Synthesis of 3-Amino-2-carboxamide Tetrahydropyrrolo[2,3-b]quinolines","volume":"27","author":"Barker","year":"2016","journal-title":"Synlett"},{"key":"ref_21","unstructured":"Haverkate, N.A. (2017). Synthesis and Investigation of Anti-proliferative Thieno[2,3-b]pyridine Derivatives with Enhanced Solubility. [Master\u2019s Thesis, University of Auckland]."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ejmech.2014.09.001","article-title":"Synthesis and cytotoxicity of thieno[2,3-b]pyridine and furo[2,3-b]pyridine derivatives","volume":"86","author":"Hung","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1021\/acs.jmedchem.6b00788","article-title":"Covalent Modifiers: A Chemical Perspective on the Reactivity of \u03b1,\u03b2-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions","volume":"60","author":"Jackson","year":"2017","journal-title":"J. Med. Chem."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/12\/2020\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:36:21Z","timestamp":1760168181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/13\/12\/2020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,26]]},"references-count":23,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["pharmaceutics13122020"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics13122020","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,26]]}}}